EXHANCE-3: A Phase 3, Three-Month Study of Safety and Efficacy of Fluticasone Propionate Exhalation Delivery System (FLU-EDS) in Patients With Chronic Rhinosinusitis With (CRSwNP) and Without Nasal Polyps (CRSsNP)

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2016.12.261
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search